| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 |
Form 4: Deardorf Caren, Director
Received 755 shares as a grant or award · Granted 1,020 Common Share Options |
| 13 Nov 2026 |
Form 3: Deardorf Caren, Director
No securities owned |
| 12 Nov 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On November 5, 2026, the board of directors (the “Board”) of Alpha Cognition Inc. (the “Company”) appointed Caren Deardorf as a director of the Company effective November 11, 2026. |
| 12 Nov 2026 | QUARTERLY REPORT |
| 26 Oct 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 17,117 shares ($143K) · Bought 14,973 shares ($123K) |
| 19 Oct 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 22,657 shares ($191K) · Bought 14,283 shares ($118K) |
| 02 Oct 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 19,050 shares ($166K) |
| 28 Sep 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 18,337 shares ($157K) · Bought 13,426 shares ($114K) |
| 23 Sep 2026 | SCHEDULE 13G |
| 16 Sep 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 40,373 shares ($351K) · Bought 3,375 shares ($28.8K) · Bought 80,170 shares ($683K) |
| 24 Aug 2026 |
Form 4: Wills Robert James, Director
Bought 10,000 shares ($96.2K) |
| 13 Aug 2026 | QUARTERLY REPORT |
| 04 Aug 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 2,900 shares ($23K) · Bought 50,000 shares ($400K) |
| 28 Jul 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 130 shares ($1.03K) |
| 24 Jul 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 150,237 shares ($1.18M) · Bought 49,849 shares ($389K) |
| 24 Jul 2026 | SCHEDULE 13G/A |
| 29 Jun 2026 |
Form 4: Opaleye Management Inc., 10% owner
Bought 197 shares ($1.28K) · Bought 152,336 shares ($975K) |
| 29 Jun 2026 | SCHEDULE 13G/A |
| 23 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
On June 16, 2026, following Alpha Cognition Inc.’s (the “Company”) 2026 annual meeting of stockholders on June 16, 2026 (the “Meeting”), the board of directors (the “Board”) of the Copmany appointed Dr. Robert Wills as non-executive Chai... |
Loading...